A fast universal immobilization of immunoglobulin G at 4 °C for the development of array-based immunoassays

PLoS One. 2012;7(12):e51370. doi: 10.1371/journal.pone.0051370. Epub 2012 Dec 7.

Abstract

To maintain the antibody activity and enhance performance of array-based immunoassays, protein G was used to allow a shorter duration of immunoglobulin G immobilization at 4 °C, with the antibody placed in the appropriate orientation. The multiplexed detection of six pain-related message molecules (PRMMs) was used as examples for the development of array-based immunoassays: substance P, calcitonin gene-related peptide, nerve growth factor, brain-derived neurotrophic factor, tumor necrosis factor-α, and β-endorphin. Protein G- and non-protein G-coated slides were tested. Compared to non-protein G immunoassays, protein G shortened the antibody immobilization time at 4 °C from overnight to 2 hours. Only protein G-facilitated immunoassays succeeded in simultaneously detecting all six PRMMs with high specificity. Dose-response curves showed that the limits of detection of the protein G-multiplexed immunoassays for the PRMMs was approximately 164, 167, 120, 60, 80, and 92 pg/ml, respectively. Thus, protein G effectively shortens the duration of antibody immobilization at 4 °C, allowing the use of sensitive array-based immunoassays for the simultaneous detection of PRMMs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Immobilized*
  • Bacterial Proteins* / metabolism
  • Brain-Derived Neurotrophic Factor
  • Calcitonin Gene-Related Peptide
  • Dose-Response Relationship, Drug
  • Immunoassay / methods*
  • Immunoglobulin G*
  • Nerve Growth Factor
  • Substance P
  • Temperature
  • Tumor Necrosis Factor-alpha
  • beta-Endorphin

Substances

  • Antibodies, Immobilized
  • Bacterial Proteins
  • Brain-Derived Neurotrophic Factor
  • IgG Fc-binding protein, Streptococcus
  • Immunoglobulin G
  • Tumor Necrosis Factor-alpha
  • Substance P
  • beta-Endorphin
  • Nerve Growth Factor
  • Calcitonin Gene-Related Peptide

Grants and funding

This work was partially supported by grants from the National Science Council, Taiwan (97-2311-B-019-001-MY2), Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST99-G4-1), the National Central University and Landseed Hospital Program (NCU-LSH-100-A-012), the Cathay General Hospital (CGH-MR-9917 and CGH-MR-10019), the joint grant from National Central University and Cathay General Hospital (99CGH-NCU-A2), and the National Central University and Taipei Medical University Hospital Program (100TMUH-NCU-005). The authors also thank the Center for Dynamical Biomarkers and Translational Medicine (CDBTM) and the Ministry of Education, Taiwan for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.